OrganiGram Holdings (OrganiGram Holdings) Research & Development : $8.38 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is OrganiGram Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. OrganiGram Holdings's Research & Development for the three months ended in Dec. 2023 was $3.33 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $8.38 Mil.

OrganiGram Holdings Research & Development Historical Data

The historical data trend for OrganiGram Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrganiGram Holdings Research & Development Chart

OrganiGram Holdings Annual Data

Trend

Apr12

Apr13

Apr14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Research & Development

Get a 7-Day Free Trial

0.31

0.96

2.89

OrganiGram Holdings Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Dec23
Research & Development	Get a 7-Day Free Trial															1.85	1.77	2.49	2.56	3.33

OrganiGram Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.38 Mil.

OrganiGram Holdings (NAS:OGI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

OrganiGram Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of OrganiGram Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

OrganiGram Holdings (OrganiGram Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OrganiGram Holdings Inc (NAS:OGI) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

0OG0:Germany 0OG0:Germany OGI:Canada

Address

145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8

Website

https://www.organigram.ca

OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.